RPRX
Repros Therapeutics Inc.
RPRX
RPRX
Delisted
RPRX was delisted on the 31st of January, 2018.
58 hedge funds and large institutions have $104M invested in Repros Therapeutics Inc. in 2015 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
32% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 19
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
58
Holding in Top 10
–
Calls
$12.7M
Puts
$3.38M
Top Buyers
| 1 | +$2.68M | |
| 2 | +$1.64M | |
| 3 | +$908K | |
| 4 |
Barclays
London,
United Kingdom
|
+$802K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$442K |
Top Sellers
| 1 | -$2.92M | |
| 2 | -$1.21M | |
| 3 | -$1.17M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$1.06M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$794K |